Cécile Marie Chloé Réal
Vorstandsvorsitzender bei Bioprofile SA
Profil
Cécile Marie Chloé Réal is the founder of Endodiag SAS and Medevice Accelerator SAS, both founded in 2011.
At Endodiag SAS, she holds the title of Chief Executive Officer, and at Medevice Accelerator SAS, she holds the title of President.
Ms. Réal is also the founder of Abolis Biotechnologies SAS.
Currently, she is the Chief Executive Officer at Bioprofile SA.
Aktive Positionen von Cécile Marie Chloé Réal
Unternehmen | Position | Beginn |
---|---|---|
Bioprofile SA
Bioprofile SA Medical SpecialtiesHealth Technology Bioprofile SA develops, manufactures and markets orthopedic implants. The firm's main activities include developing, manufacturing and marketing of orthopedic implants intended to replace joints for patients suffering from arthritis. Bioprofile manufactures its orthopedic implants made of pyrolytic carbon or pyrocarbon. The company was founded by Cécile Réal in 1999 and is headquartered in Grenoble, France. | Vorstandsvorsitzender | - |
Endodiag SAS
Endodiag SAS BiotechnologyHealth Technology Endodiag SAS develops diagnosis solutions which focused on patient screening and individual endometriosis characteristics. It offers early diagnosis, guiding decisions and new therapies. The company was founded by Jean Gogusev, Patric Henri, Cecile Marie Chloe Real and Jean Bouquet de la Joliniere in 2011 and is headquartered in Evry Cedex, France. | Vorstandsvorsitzender | 18.01.2011 |
Medevice Accelerator SAS
Medevice Accelerator SAS Investment ManagersFinance Medevice Accelerator SAS (Medevice Accelerator) is an independent venture capital firm founded in 2011 by Cécile Réal. The firm is located in Chavanod (Alpes), France. | Gründer | 26.08.2011 |
Abolis Biotechnologies SAS
Abolis Biotechnologies SAS BiotechnologyHealth Technology Abolis Biotechnologies SAS is a French industrial biotechnology company with a strong expertise in metabolic engineering for biosynthesis. The company is based in Evry, France and was founded in 2014 by Cyrille Pauthenier, Anthony Tschirhard, Jean-Loup Faulon, Cécile Marie Chloé Réal. The company has in-house know-how and unique tools to design and optimize metabolic pathways transforming sugars into molecules of interest. Abolis is developing bio-production processes for chemical molecules by fermentation of biomass. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Bioprofile SA
Bioprofile SA Medical SpecialtiesHealth Technology Bioprofile SA develops, manufactures and markets orthopedic implants. The firm's main activities include developing, manufacturing and marketing of orthopedic implants intended to replace joints for patients suffering from arthritis. Bioprofile manufactures its orthopedic implants made of pyrolytic carbon or pyrocarbon. The company was founded by Cécile Réal in 1999 and is headquartered in Grenoble, France. | Health Technology |
Endodiag SAS
Endodiag SAS BiotechnologyHealth Technology Endodiag SAS develops diagnosis solutions which focused on patient screening and individual endometriosis characteristics. It offers early diagnosis, guiding decisions and new therapies. The company was founded by Jean Gogusev, Patric Henri, Cecile Marie Chloe Real and Jean Bouquet de la Joliniere in 2011 and is headquartered in Evry Cedex, France. | Health Technology |
Medevice Accelerator SAS
Medevice Accelerator SAS Investment ManagersFinance Medevice Accelerator SAS (Medevice Accelerator) is an independent venture capital firm founded in 2011 by Cécile Réal. The firm is located in Chavanod (Alpes), France. | Finance |
Abolis Biotechnologies SAS
Abolis Biotechnologies SAS BiotechnologyHealth Technology Abolis Biotechnologies SAS is a French industrial biotechnology company with a strong expertise in metabolic engineering for biosynthesis. The company is based in Evry, France and was founded in 2014 by Cyrille Pauthenier, Anthony Tschirhard, Jean-Loup Faulon, Cécile Marie Chloé Réal. The company has in-house know-how and unique tools to design and optimize metabolic pathways transforming sugars into molecules of interest. Abolis is developing bio-production processes for chemical molecules by fermentation of biomass. | Health Technology |